Why Imaging and Pathology May Describe Cancer Differently

Scans and pathology reports often describe what sounds like the same tumor in terms that do not match. The scan says 3.2 centimeters; the pathology report says 2.4. The scan mentions one area; the pathology finds two. The scan calls lymph nodes enlarged; the pathology calls them negative. This is expected. It is usually not an error by either side.

Imaging measures how tissue looks from the outside: density, shape, edges, and how it takes up contrast. Pathology measures what the cells actually are, under a microscope, in a specimen that has been cut, processed and stained. The two tests answer different questions with different tools. So their numbers rarely match exactly.

Several ordinary things move the measurement.

A scan measures the whole disturbed area. Around many tumors sits swelling, inflammation, squashed normal tissue and the body's reaction to the tumor. On imaging, all of that blends into the mass. Under the microscope it is clearly not cancer, so the pathologist leaves it out and reports a smaller number.

Tissue changes once it is removed. Specimens shrink when they lose their blood supply. They shrink again during fixation in formalin. A tumor measured inside a living body and the same tumor measured on a cutting board are not measured under the same conditions.

The planes are different. A radiologist measures the longest axis visible on one particular slice. A pathologist measures the longest axis on whatever plane the specimen was cut. Neither is wrong. They are simply not the same line through the same object.

Contrast timing and image resolution matter too. On MRI in particular, the enhancing area can overstate or understate how far the disease really goes. That is well described, not surprising.

Staging shows this ranking directly. Clinical stage is written with a lowercase c, as in cT2 cN1. It is the estimate put together before treatment, from physical examination, imaging and any early biopsy. Pathologic stage is written with a lowercase p, as in pT2 pN0. It comes from tissue that was actually examined after surgery. Pathologic stage is generally the more precise of the two. It rests on direct examination of cells, not on reading shadows.

That is why a treatment plan can shift after surgery even though the cancer itself has not changed. What changed is the quality of the information.

Imaging judges lymph nodes mostly by size and shape, because a scan cannot see inside one. Nodes get bigger for many reasons that have nothing to do with cancer. Recent infection, inflammation, and the immune response to a nearby biopsy all do it. Meanwhile a normal-sized node can hold a small deposit of cancer that no scan could pick up.

So imaging can call nodes suspicious that pathology finds clean. And imaging can call nodes normal that pathology finds involved. Both happen. Both are limits of resolution rather than mistakes.

When treatment is given before surgery, the two tests drift further apart. That gap is itself informative. Treated tumors leave behind fibrous scar tissue, dead cells and inflammation. All of that can still show up as a mass on imaging, even when little or no living cancer remains. The reverse also happens. Scattered surviving cells can sit in an area that imaging now calls resolved. Staging after such treatment carries a y prefix, as in ypT1 ypN0, exactly because everyone understands it to be a different measurement.

Do not try to reconcile the numbers yourself. Ask which report your treatment plan is based on, and whether the difference changes anything. Most of the time the answer is that pathology governs and the gap is routine. If a difference is large enough to matter, that is a specific conversation worth having. It is also the situation where a second review of the slides or the images is sometimes arranged. That is a normal part of oncology practice, not a sign that someone made an error.

• NCI - Pathology Reports Fact Sheet
• NCI Dictionary - Clinical Staging
• NCI Dictionary - Pathologic Staging